Work
Testimony of David J. Graham, November 18, 2004
FDA drug-safety scientist David Graham's written testimony to the Senate Finance Committee on Vioxx.
- Dates
- 18 Nov 2004
Connections 1
author
- David Graham 18 Nov 2004 Primary record 1
Timeline 2 dates
- 18 Nov 2004 Testimony of David J. Graham, November 18, 2004
- 18 Nov 2004 David Graham authored Testimony of David J. Graham, November 18, 2004
Proof 1 source
-
Testimony of David J. Graham, MD, MPH, November 18, 2004, U.S. Senate Committee on Finance, 18 Nov 2004.
Primary record
Archived copy
Testimony of David J. Graham, MD, MPH, November 18, 2004
Among many things, this report estimated that nearly 28,000 excess cases of heart attack or sudden cardiac death were caused by Vioxx.
This estimate ranges from 88,000 to 139,000 Americans.
I was pressured to change my conclusions and recommendations
regulate as its client, over-values the benefits of the drugs it approves and seriously under-values,
Page history 1 change
- Add 55 stories, each checked against its sources96e92fe6
Something wrong or missing? Tell us, with a source, or edit this page.